Examples of GLP-1 receptor agonists

This medicine group includes agents such as semaglutide, liraglutide, dulaglutide, and exenatide. They mimic GLP-1, a hormone released after eating. Their effects can include glucose-dependent insulin release, reduced glucagon release, slower stomach emptying, and lower appetite. Names and formulations can vary between countries, and a product used for diabetes may not have the same approved indication as a product used for weight management.

Use only the product prescribed for you, following its injection or tablet instructions. Do not substitute a different brand or active ingredient because the devices, schedules, and dose increases may differ. Keep a record of nausea, vomiting, constipation, diarrhoea, appetite changes, and glucose readings. Tell your clinician about previous pancreatitis, gallbladder problems, severe digestive disease, pregnancy plans, or medicines that affect glucose.

Get urgent help for severe abdominal pain that may spread to the back, repeated vomiting with inability to drink, fainting, confusion, or trouble breathing. Seek prompt advice for yellowing of the skin, fever with upper abdominal pain, or a severe allergic reaction such as facial swelling or wheezing. Do not take another dose until a clinician advises you if a serious reaction is suspected.

Ask which active ingredient and formulation you are being offered, why it fits your goals, how the dose will be increased, and what to do after a missed dose. Confirm storage, injection technique, and whether other glucose medicines need adjustment.